Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 0 | 1 | 1 |
| Accounts receivable | 21 | 11 | 60 | -45 | 68 |
| Other Working Capital | 603 | -186 | -748 | 3,541 | 706 |
| Other Operating Activity | -1,392 | -3,116 | -5,338 | -16,557 | -9,081 |
| Operating Cash Flow | $-768 | $-3,291 | $-6,026 | $-13,060 | $-8,307 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -30 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 0 | 281 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 0 | -3,000 |
| Investing Cash Flow | $-30 | $N/A | $N/A | $0 | $-2,719 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 65 | 155 | 152 | 152 | 170 |
| Debt Repayment | -26 | -195 | -152 | -152 | -149 |
| Common Stock Issued | 0 | 2,017 | 4,198 | 376 | 28,669 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,447 |
| Financing Cash Flow | $39 | $1,977 | $4,198 | $376 | $26,244 |
| Beginning Cash Position | 773 | 2,087 | 3,916 | 16,600 | 1,381 |
| End Cash Position | 15 | 773 | 2,087 | 3,916 | 16,600 |
| Net Cash Flow | $-759 | $-1,314 | $-1,828 | $-12,684 | $15,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -768 | -3,291 | -6,026 | -13,060 | -8,307 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -3,000 |
| Free Cash Flow | -768 | -3,291 | -6,026 | -13,060 | -11,307 |